Chronic kidney disease market seen reaching $101.87 billion by 2030
The global chronic kidney disease market is projected to grow from $74.87 billion in 2025 to $101.87 billion by 2030, according to The Business Research Company. Rising diabetes and hypertension cases, more dialysis access and new kidney therapies are driving demand.
Why it matters: - Chronic kidney disease affects kidney function, driving long-term care needs and raising demand for dialysis, diagnostics and transplant-related services. - The market’s growth reflects rising patient volumes and a broader shift toward earlier detection, home-based treatment and preventive nephrology. - The expansion creates commercial opportunities for healthcare providers, drug developers, dialysis operators and monitoring platforms.
What happened: - The Business Research Company said the chronic kidney disease market will grow from $74.87 billion in 2025 to $79.43 billion in 2026. - The company projects the market will reach $101.87 billion by 2030. - The report forecasts a 6.1% CAGR from 2025 to 2026 and a 6.4% CAGR from 2026 to 2030. - The report is titled Chronic Kidney Disease Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The release was issued from London on Nov. 18, 2026.
The details: - Historical growth was linked to more diabetes and hypertension cases, greater availability of dialysis services, better kidney function diagnostics, higher awareness of chronic renal conditions and more nephrology care facilities. - Future growth is expected to come from new renal therapies, patient-focused dialysis solutions, digital kidney health monitoring platforms, transplant preparedness and preventive nephrology programs. - The report highlights early detection of CKD, wider use of renoprotective medications, more home-based dialysis, multidisciplinary care and efforts to slow disease progression as key trends. - CKD is described as the gradual loss of kidney function, which reduces the organ’s ability to filter blood effectively and can lead to excess fluid and waste buildup. - Diabetes, high blood pressure and obesity are common contributors to CKD. - Managing CKD requires continuous monitoring and treatment to prevent progression to end-stage renal failure, which may require dialysis or kidney transplantation. - Kidney Research UK said in June 2023 that the number of people living with CKD stages 3 to 5 in the UK is predicted to approach 3.9 million by 2033. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company says its 2026 reports add market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis.
Between the lines: - The market outlook points to a chronic disease category that is being pushed by both rising prevalence and more advanced treatment pathways. - The emphasis on digital monitoring, home dialysis and preventive care suggests providers are looking for lower-cost, more convenient ways to manage a growing patient base. - North America’s lead and Asia-Pacific’s faster growth indicate mature demand in established healthcare systems and faster expansion in high-growth markets.
What’s next: - More investment is likely in kidney health monitoring, dialysis innovation and therapies designed to slow disease progression. - The report’s forecast suggests CKD-related products and services will keep expanding as patient numbers rise through the decade. - More information is available in the full report and a free sample.
The bottom line: - Chronic kidney disease is becoming a bigger global market as demand rises for earlier detection, better management and more accessible treatment options.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Middle East Business Channel
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.